Jan Zavada

This inventor holds 26 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Cancer Immunology. Top assignees: Institute of Virology Slovak Academy of Sciences, Institute of Virology of the Slovak Academy of Sciences, Institute of Virology of the Slovak Academy of Science. Active years: 1999-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Zavada. Retrieved from https://idiyas.com/inventor/jan-zavada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 4)

% Patents Active = 53.8

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 215(Granted Patents)

Location History:

Prague, SK (2001)
Praque, CZ (2010)
Prague, CZ (1999 - 2014)

Company Filing History:

16 out of 20

Institute of Virology Slovak Academy of Sciences

patents

7 out of 18

Institute of Virology of the Slovak Academy of Sciences

patents

2 out of 2

Institute of Virology of the Slovak Academy of Science

patents

4. 1 out of 1

Institute of Virology, Solvak Academy of Sciences

patent

Years Active: 1999-2014

Loading Chart...

Areas of Expertise:

MN Gene

MN Protein

Cancer Prognosis

Carbonic Anhydrase IX

Monoclonal Antibodies

Tumor Growth Inhibition

Immunological Methods

Cancer Treatment

Antibody Detection

Antibody Therapies

MN-Specific Antibodies

Hybridomas

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8759493 - MN gene and protein (2014-06-24),

2. 8012707 - MN gene and protein (2011-09-06),

3. 7993852 - MN/CA IX and cancer prognosis (2011-08-09),

4. 7910691 - MN gene and protein (2011-03-22),

5. 7846673 - Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes (2010-12-07),

6. 7833728 - Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes (2010-11-16),

7. 7816496 - MN gene and protein (2010-10-19),

8. 7816493 - Soluble form of carbonic anhydrase IX (S-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/NEU/C-ERBB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes (2010-10-19),

9. 7741048 - MN/CA IX and cancer prognosis (2010-06-22),

10. 7713704 - MN gene and protein (2010-05-11),

11. 7524634 - MN/CA IX and cancer prognosis (2009-04-28),

12. 7186514 - MN gene and protein (2007-03-06),

13. 7115715 - Anti-idiotype antibodies to MN proteins and MN polypeptides (2006-10-03),

14. 6774117 - MN gene and protein (2004-08-10),

15. 6770438 - MN gene and protein (2004-08-03),

Title: Jan Zavada - Pioneering Inventor from Prague

Introduction: Jan Zavada is a renowned inventor hailing from the vibrant city of Prague, Czech Republic. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various fields through his groundbreaking inventions.

Latest Patents: Jan Zavada's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance energy efficiency and a cutting-edge medical device designed to improve patient outcomes in critical care settings.

Career Highlights: Throughout his illustrious career, Jan Zavada has been recognized for his innovative spirit and dedication to creating solutions that make a difference. His inventions have garnered international acclaim and have been instrumental in shaping the future of technology.

Collaborations: Jan Zavada has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work across disciplines and bring together diverse teams has been key to the success of his projects.

Conclusion: Jan Zavada's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventors. His impact on technology and society is sure to be felt for years to come.

Profile summary based on public USPTO records.